NEW YORK (GenomeWeb News) – Proteome Sciences said today that it has struck a non-exclusive license agreement with Sigma-Aldrich enabling Sigma to continue selling the ProteoPrep kits in Europe, Japan, and Australia.
The agreement gives Proteome a signing fee and royalties on all eleven of its ProteoPrep kits sold in the three regions. It also covers all future products sold under the ProteoPrep trademark that contain chemicals and reagents for the disruption of cells, tissues, or other biological material and the extraction of biological molecules like proteins, lipids, and carbohydrates.
The trademark also covers methods and processes relating to assays for diagnosing diseases and chemical markers that disrupt cells, tissues, or other materials for determining drug targets and proteins and peptides, the company said.
Further financial terms of the agreement were not disclosed.